A detailed history of Avion Wealth transactions in Geron Corp stock. As of the latest transaction made, Avion Wealth holds 2,361 shares of GERN stock, worth $2,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,361
Previous 2,000 18.05%
Holding current value
$2,644
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$1.1 - $1.47 $397 - $530
361 Added 18.05%
2,361 $3,000
Q2 2025

Jul 30, 2025

BUY
$1.18 - $1.62 $2,360 - $3,240
2,000 New
2,000 $2,000
Q3 2023

Oct 20, 2023

BUY
$2.11 - $3.28 $4,220 - $6,560
2,000 New
2,000 $4,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $423M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.